Nasdaq · CIK 0001668243
URGN UroGen Pharma Ltd.
Insider trading from SEC Form 4. Last filing 3 d ago. Close $36.83 on Oct 9, 2026, +124% from the 52-week low and -27% from the high.
Last 90 days
Net insider value
-$183k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$183k by 3 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
URGNOct 9, 2026 · close 36.83
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at UroGen Pharma Ltd., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Chris Degnan Chief Financial Officer sell | $81k 2,202 shares | -33% | +125% from low-26% from high | |
| 14Weak | Mark Schoenberg Chief Medical Officer sell | $37k 871 shares | -1% | - | |
| 16Weak | Jason Drew Smith General Counsel sell | $65k 1,519 shares | -3% | - | |
| 8Weak | Mark Schoenberg Chief Medical Officer sell | $250k 10,000 shares | -7% | +543% from low0% from high | |
| 23Weak | Chris Degnan Chief Financial Officer sell | $37k 2,203 shares | -49% | +341% from low-19% from high | |
| 8Weak | Mark Schoenberg Chief Medical Officer sell | $17k 871 shares | -1% | +445% from low0% from high | |
| 13Weak | Jason Drew Smith General Counsel sell | $29k 1,520 shares | -3% | +445% from low0% from high | |
| 35Weak | Mark Schoenberg Chief Medical Officer sell | $177k 10,000 shares | -6% | +364% from low-12% from high | |
| 18Weak | Mark Schoenberg Chief Medical Officer sell | $99k 5,149 shares | -3% | +381% from low-0% from high | |
| 24Weak | Jason Drew Smith General Counsel sell | $144k 7,522 shares | -15% | +381% from low-0% from high | |
| 6Weak | Mark Schoenberg Chief Medical Officer sell | $38k 5,162 shares | -3% | +79% from low-49% from high |
Transactions
The last 52 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Chris Degnan Chief Financial Officer | MOption exercise Ordinary Shares | +4,483 | - | - | 6,763 | 3 d ago |
| Oct 8, 2026 | Chris Degnan Chief Financial Officer | SOpen-market sale Ordinary Shares | -2,202 | $36.69 | $81k | 4,561 | 3 d ago |
| Oct 8, 2026 | Chris Degnan Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -4,483 | $0.00 | $0 | 4,484 | 3 d ago |
| Sep 7, 2026 | Mark Schoenberg Chief Medical Officer | MOption exercise Ordinary Shares | +1,667 | - | - | 60,753 | 33 d ago |
| Sep 7, 2026 | Jason Drew Smith General Counsel | MOption exercise Ordinary Shares | +3,334 | - | - | 54,660 | 33 d ago |
| Sep 8, 2026 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares | -871 | $42.92 | $37k | 59,882 | 33 d ago |
| Sep 8, 2026 | Jason Drew Smith General Counsel | SOpen-market sale Ordinary Shares | -1,519 | $42.54 | $65k | 53,141 | 33 d ago |
| Sep 7, 2026 | Mark Schoenberg Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -1,667 | $0.00 | $0 | 0 | 33 d ago |
| Sep 7, 2026 | Jason Drew Smith General Counsel | MOption exercise Restricted Stock Unitsderivative | -3,334 | $0.00 | $0 | 0 | 33 d ago |
| Jan 31, 2026 | Elizabeth A. Barrett Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +153,195 | $0.00 | $0 | 153,195 | Feb 19, 2026 |
| Jan 31, 2026 | Chris Degnan Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +32,609 | $0.00 | $0 | 32,609 | Feb 3, 2026 |
| Nov 26, 2025 | Cynthia M Butitta director | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | Stuart Holden director | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | James A. Robinson Jr. director | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | Leana Wen director | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | Daniel George Wildman director | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | Stuart Holden director | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Nov 26, 2025 | Leana Wen director | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Nov 26, 2025 | Daniel George Wildman director | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Nov 26, 2025 | James A. Robinson Jr. director | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Nov 26, 2025 | Cynthia M Butitta director | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Nov 19, 2025 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares10b5-1 | -10,000 | $25.00 | $250k | 139,025 | Nov 20, 2025 |
| Oct 8, 2025 | Chris Degnan Chief Financial Officer | MOption exercise Ordinary Shares | +4,483 | - | - | 4,483 | Oct 9, 2025 |
| Oct 8, 2025 | Chris Degnan Chief Financial Officer | SOpen-market sale Ordinary Shares | -2,203 | $16.85 | $37k | 2,280 | Oct 9, 2025 |
| Oct 8, 2025 | Chris Degnan Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -4,483 | $0.00 | $0 | 8,967 | Oct 9, 2025 |
| Sep 7, 2025 | Jason Drew Smith General Counsel | MOption exercise Ordinary Shares | +3,333 | - | - | 44,825 | Sep 9, 2025 |
| Sep 7, 2025 | Mark Schoenberg Chief Medical Officer | MOption exercise Ordinary Shares | +1,667 | - | - | 149,896 | Sep 9, 2025 |
| Sep 8, 2025 | Jason Drew Smith General Counsel | SOpen-market sale Ordinary Shares | -1,520 | $19.11 | $29k | 43,305 | Sep 9, 2025 |
| Sep 8, 2025 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares | -871 | $19.11 | $17k | 149,025 | Sep 9, 2025 |
| Sep 7, 2025 | Jason Drew Smith General Counsel | MOption exercise Restricted Stock Unitsderivative | -3,333 | $0.00 | $0 | 3,334 | Sep 9, 2025 |
| Sep 7, 2025 | Mark Schoenberg Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -1,667 | $0.00 | $0 | 1,667 | Sep 9, 2025 |
| Aug 26, 2025 | Daniel George Wildman director | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | Leana Wen director | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | James A. Robinson Jr. director | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | Arie Belldegrun director | AGrant or award Stock Option (right ot buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Aug 27, 2025 |
| Aug 26, 2025 | Cynthia M Butitta director | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | Stuart Holden director | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | Stuart Holden director | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Aug 26, 2025 | James A. Robinson Jr. director | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Aug 26, 2025 | Cynthia M Butitta director | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Aug 26, 2025 | Leana Wen director | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Aug 26, 2025 | Daniel George Wildman director | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Aug 11, 2025 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares | -10,000 | $17.69 | $177k | 148,229 | Aug 13, 2025 |
| Jul 28, 2025 | Elizabeth A. Barrett Chief Executive Officer | AGrant or award Performance Stock Unitsderivative | +87,615 | $0.00 | $0 | 87,615 | Jul 30, 2025 |
| Jul 28, 2025 | Jason Drew Smith General Counsel | MOption exercise Ordinary Shares | +16,500 | - | - | 49,014 | Jul 30, 2025 |
| Jul 28, 2025 | Mark Schoenberg Chief Medical Officer | MOption exercise Ordinary Shares | +10,000 | - | - | 163,378 | Jul 30, 2025 |
| Jul 28, 2025 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares | -5,149 | $19.14 | $99k | 158,229 | Jul 30, 2025 |
| Jul 28, 2025 | Jason Drew Smith General Counsel | SOpen-market sale Ordinary Shares | -7,522 | $19.14 | $144k | 41,492 | Jul 30, 2025 |
| Jun 8, 2025 | Mark Schoenberg Chief Medical Officer | MOption exercise Ordinary Shares | +10,000 | - | - | 158,540 | Jun 11, 2025 |
| Jun 9, 2025 | Mark Schoenberg Chief Medical Officer | SOpen-market sale Ordinary Shares | -5,162 | $7.37 | $38k | 153,378 | Jun 11, 2025 |
| Jun 8, 2025 | Mark Schoenberg Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | Jun 11, 2025 |
| Jan 31, 2025 | Elizabeth A. Barrett Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +96,377 | $0.00 | $0 | 96,377 | Feb 4, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Cynthia M Butittadirector
- Elizabeth A. BarrettChief Executive Officer
- Arie Belldegrundirector, owner
- Chris DegnanChief Financial Officer
- Stuart Holdendirector
- James A. Robinson Jr.director
- Mark SchoenbergChief Medical Officer
- Jason Drew SmithGeneral Counsel
- Leana Wendirector
- Daniel George Wildmandirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.